Terazosin Capsule
Product Images NDC 71610-720

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Terazosin (NDC 71610-720). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 2 mg (71610 0720 30)

Terazosin Hydrochloride 2 mg oral capsules package label showing 30 capsules. The label includes storage instructions, safety warnings, manufacturing and packaging information by Aphena Pharma Solutions - Tennessee, LLC, and features barcodes and product identification codes.*

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Terazosin Hydrochloride Chemical Structure (Terazosin Hydrochloride Capsules 1)

Chemical structure of Terazosin Hydrochloride shown as a detailed molecular diagram with specific functional groups and an attached hydrochloride component.*

FDA Label Image

Figure 1 (Terazosin Hydrochloride Capsules 2)

A side-by-side line graph showing mean changes from baseline over 3 months. The left graph depicts mean change in total symptom score for terazosin and placebo groups, with terazosin showing greater symptom score reduction. The right graph shows mean increase in peak flow rate (mL/sec) for terazosin and placebo, with terazosin demonstrating higher peak flow improvement.*

FDA Label Image

Figure 2 (Terazosin Hydrochloride Capsules 3)

A line chart depicting mean change from baseline over 30 months, with data points marked from month 0 to month 30. The vertical axis shows mean change values, and several points are noted with asterisks, indicating statistical significance or special attention. The horizontal axis is labeled in months.*

FDA Label Image

Figure 3 (Terazosin Hydrochloride Capsules 4)

Line graph showing mean change from baseline in mL/sec over 30 months. The x-axis represents months from 0 to 30, and the y-axis shows mean change values ranging approximately from 0 to 4.5. Data points include error bars and several are marked with asterisks, indicating statistical significance at those time points.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.